Prognosis of castration-resistant prostate cancer patients–use of the AdnaTest® system for detection of circulating tumor cells
…, M Jančíková, H Honova, K Kološtová… - Anticancer …, 2016 - ar.iiarjournals.org
Background: Detection of circulating tumor cells (CTC) in patients with castration-resistant
prostate cancer (CRPC) may improve the estimate of chemotherapy response. We evaluated …
prostate cancer (CRPC) may improve the estimate of chemotherapy response. We evaluated …
Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success
…, M Kubecova, P Tesařová, V Bobek, K Kološtová - in vivo, 2014 - iv.iiarjournals.org
Circulating tumor cells (CTCs) are an independent prognostic factor for patients with metastatic
breast cancer (MBC). However, the role of CTCs in early breast cancer management is …
breast cancer (MBC). However, the role of CTCs in early breast cancer management is …
[HTML][HTML] Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?
…, M Pinkas, M Zemanová, K Kološtová… - American journal of …, 2017 - ncbi.nlm.nih.gov
Circulating tumor cells (CTC) present in peripheral blood are assigned precursors of advanced
tumor disease. Simplicity of blood withdrawal procedure adds practically an unlimited …
tumor disease. Simplicity of blood withdrawal procedure adds practically an unlimited …
Adjuvant effect of Bacillus firmus on the expression of cytokines and toll-like receptors in mouse nasopharynx-associated lymphoid tissue (NALT) after intranasal …
…, M Havlíčková, O Novotná, M Jirkovská, K Kološtová… - Immunology …, 2010 - Elsevier
Due to the persisting threat of development of new highly pathogenic influenza A subtypes, a
mucosal vaccination which would induce a potent and cross-protective reaction is desirable…
mucosal vaccination which would induce a potent and cross-protective reaction is desirable…
Gene expression analysis of immunomagnetically enriched circulating tumor cell fraction in castration-resistant prostate cancer
…, V Mikulová, O Čapoun, D Švec, K Kološtová… - Molecular Diagnosis & …, 2018 - Springer
Background Molecular characterization of tumors could be a key to therapeutic decision-making
with regards to targeted therapies in castration-resistant prostate cancer (CRPC). A …
with regards to targeted therapies in castration-resistant prostate cancer (CRPC). A …
Nanoparticles Based on Poly(trimethylene carbonate) Triblock Copolymers with Post-Crystallization Ability and Their Degradation in vitro
Aliphatic polycarbonate-based block copolymers have received considerable attention as
carriers for targeted drug and gene delivery because of their biocompatibility and …
carriers for targeted drug and gene delivery because of their biocompatibility and …
Circulating tumor cells and prostate cancer prognosis
…, M Jančíková, H Honová, K Kološtová… - Casopis Lekaru …, 2014 - europepmc.org
Prostate cancer (PC) is the most common malignant disease in men. Prognosis of patients
with metastatic PC is generally unfavourable; however there are significant differences in …
with metastatic PC is generally unfavourable; however there are significant differences in …
AR-V7 Androgen Receptor Variant as a Predictor of Response to Androgen-receptor Targeting Agents Used to Treat Castration-refractory Metastatic Prostate Cancer
T Büchler, V Bobek, K Kološtová - Klinicka Onkologie: Casopis …, 2017 - europepmc.org
Background Several systemic treatment options are currently available for patients with
metastatic castration-refractory prostate cancer (mCRPC), including the androgen-receptor …
metastatic castration-refractory prostate cancer (mCRPC), including the androgen-receptor …
Vyšetření cirkulujících nádorových buněk u karcinomu ledviny.
…, J Šonský, E Pospíšilová, K Kološtová… - Czech Urology …, 2020 - search.ebscohost.com
Klézl P, Šonský J, Pospíšilová E, Kološtová K, Bo‑bek V, Grill R. Examination of circulating
tumor cells in renal carcinoma. Serial examination of circulating tumor cell pre‑sence after …
tumor cells in renal carcinoma. Serial examination of circulating tumor cell pre‑sence after …
Gene expression profiling in circulating cells (CTCs) of breast carcinoma patients-a tool for early metastasis detection and therapy individualization
S Kasimir-Bauer, K Kološtová, D Pinterova, V Bobek… - Cancer Research, 2010 - AACR
Background: Tumor cell dissemination is an early process in breast cancer (BC) and
circulating tumor cells (CTCs) are considered potential surrogate marker for the detection and …
circulating tumor cells (CTCs) are considered potential surrogate marker for the detection and …